Skip to main content
. 2022 Feb 18;76(3):620–634. doi: 10.1007/s12020-022-03011-0

Table 3.

Laboratory results of patients with DTD (N = 17)

Laboratory results N Normal range Mean value (range)a
FT3, pmol/L 3.1–6.8 5.63 ± 3.53 (3.65–19.07)
 Normal 16 (94.1) 4.79 ± 0.74 (3.65–6.39)
 Increase 1 (5.9) /
 Decrease 0 (0.0) /
FT4, pmol/L 12–22 19.59 ± 12.14 (6.09–61.29)
 Normal 12 (70.6) 16.60 ± 2.40 (13.84–21.44)
 Increase 3 (17.6) 38.97 ± 20.04 (22.50–61.29)
 Decrease 2 (11.8) 8.48 ± 11.38 (6.09–10.86)
TSH, µIU/mL 0.27–4.2 4.39 ± 8.56 (0.01–36.31)
 Normal 10 (58.9) 2.35 ± 1.07 (0.63–3.96)
 Increase 3 (17.6) 17.01 ± 16.85 (5.25–36.31)
 Decrease 4 (23.5) 0.05 ± 0.07 (0.01–0.15)
TPO Ab (+), IU/mL 12 (70.6) 0–34 229.96 ± 295.57 (5–856)
Tg Ab (+), IU/mL 12 (70.6) 0–115 619.89 ± 866.92 (18.28–2905)
TR Ab (+), U/L 2 (11.8) 0–1.75 8.44 ± 5.49 (4.56–12.32)

The data in parentheses are percentages

FT3 Free triiodothyronine, FT4 Free thyroxine, TSH Thyrotropin, TPO AbThyroid peroxidase antibody, Tg Ab Thyroglobulin antibody, TR Ab TSH receptor antibody

aThe data are expressed as means ± standard deviation, with ranges in parentheses